This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Night blindness is caused by vitamin A deficiency, congenital mutations, and other eye diseases. Learn about symptoms, causes ...

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative ...

From players to watch to pedigree and much more, we set out what to epect from Portugal at the European Championship ...

Two-year data from a phase 1/2 trial of eyeDNA Therapeutics' gene therapy for retinitis pigmentosa sets up pivotal trials, says the new biotech.

Los Angeles David Geffen School of Medicine and the Doheney Eye Institute, the VAC will be a strategic team informing Nanoscope’s scientific, clinical, and community-facing efforts. “As retina ...

An eye test that helps to check the visual accuracy of your eyes. It is a self test to monitor the patient’s central visual field, an effective method to check macular degeneration in the eyes.

An eye test that helps to check the visual accuracy of your eyes. It is a self-test to check a person’s eyesight, contains a test chart to measure a person’s vision.

Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli. | Ocular Therapeutix is making sure its corporate vision ...

Advancements in polymer science are transforming the retinal disease treatment landscape, addressing clinical challenges such as treatment invasiveness, patient adherence, and drug clearance.

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

Researchers link early cone dysfunction in RPGR-related retinal dystrophy to high myopia, with timing of degeneration ...